ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Astonea Labs IPO Details

Bookbuilding IPO | ₹38 Cr | Listed at BSE SME | Tue, May 27, 2025 - Thu, May 29, 2025

IPO Details
Messages
Stock Price
Subscription
Reviews
BoA
Astonea Labs IPO Logo

Astonea Labs IPO is a book build issue of ₹37.67 crores. The issue is entirely a fresh issue of 0.28 crore shares of ₹37.67 crore.

Astonea Labs IPO bidding started from May 27, 2025 and ended on May 29, 2025. The allotment for Astonea Labs IPO was finalized on May 30, 2025. The shares got listed on BSE SME on Jun 3, 2025.

Astonea Labs IPO price band is set at ₹135 per share. The lot size for an application is 1,000. The minimum amount of investment required by an retail is ₹1,35,000 (1000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (2,000 shares), amounting to ₹2,70,000.

Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Basan Equity Broking Ltd..

Refer to Astonea Labs IPO RHP for detailed Information.

IPO Open

Tue, May 27, 2025

IPO Close

Thu, May 29, 2025

Issue Price

₹135 per share

Market Cap (Pre-IPO)

₹141.90 Cr

IPO Details

IPO Date27 to 29 May, 2025
Listed onTue, Jun 3, 2025
Face Value₹10 per share
Price Band₹128 to ₹135
Issue Price₹135 per share
Lot Size1,000 Shares
Sale TypeFresh capital only
Issue TypeBookbuilding IPO
Listing AtBSE SME

Total Issue Size27,90,000 shares
(agg. up to ₹38 Cr)
Reserved for Market Maker
1,44,000 shares
(agg. up to ₹2 Cr)
Basan Equity Broking Ltd.
Fresh Issue
(Ex Market Maker)		26,46,000 shares
(agg. up to ₹36 Cr)
Net Offered to Public26,46,000 shares
(agg. up to ₹36 Cr)
Share Holding Pre Issue77,21,000 shares
Share Holding Post Issue1,05,11,000 shares
BSE Script Code 544409
ISININE0TG901011

IPO Timetable

IPOs Timetable

Issue Reservation

Astonea Labs IPO comprises a total issue size of 27,90,000 shares. The net offer to the public is 26,46,000 shares, after excluding 1,44,000 shares allotted on a firm basis. Of the Net offer 13,20,000 (49.89%) are allocated to QIB, 3,99,000 (15.08%) allocated to NII 9,27,000 (35.03%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
QIB Shares Offered 13,20,00049.89%47.31%
  − Anchor Investor Shares Offered 7,90,00028.32%
  − QIB (Ex. Anchor) Shares Offered 5,30,00019.00%
NII (HNI) Shares Offered 3,99,00015.08%14.30%
Retail Shares Offered 9,27,00035.03%33.23%
Firm Reservations
Market Maker Shares Offered 1,44,0005.16%
Total Shares Offered 27,90,000100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 1,000 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 1,000 ₹1,35,000
Retail (Max) 1 1,000 ₹1,35,000
HNI (Min) 2 2,000 ₹2,70,000
IPO Subscription Details

IPO Anchor Investors

Astonea Labs IPO raises ₹10.67 crore from anchor investors. Astonea Labs IPO Anchor bid date is May 26, 2025.
📝 Anchor Investors Letter (PDF)

Bid DateMon, May 26, 2025
Shares Offered7,90,000
Anchor Portion (₹ Cr.)10.67
Anchor lock-in period end date for 50% shares (30 Days)Sun, Jun 29, 2025
Anchor lock-in period end date for remaining shares (90 Days)Thu, Aug 28, 2025
IPO Anchor Investors List

About Astonea Labs Ltd.

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally.

The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more.

The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards.

The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands "Glow Up" and "Regero," plans to launch "Avicel," and exports to countries like Iraq and Yemen.

Produts and Offerings:

  • Products under our own brands: The company markets “Glow Up” skincare and “Regero” pharma products, offering diverse affordable solutions.
  • Products under contract manufacturing: The company provides pharmaceutical and cosmetic products under contract manufacturing, primarily for domestic and export markets.

As of August 16, 2024, the company had 217 employees on payroll.

Competitive Strengths:

  • Experienced management and dedicated employee base
  • Scalable business model
  • Wide and diverse range of product offerings
  • Quality Service

Company Financials (Restated)

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets96.5280.8964.2852.91
Total Income69.6980.2967.2630.17
Profit After Tax4.103.810.670.25
NET Worth17.2811.978.167.49
Reserves and Surplus9.564.374.163.49
Total Borrowing49.4842.4035.9929.52
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Funding of expenses proposed to be incurred towards registration in Bolivia, South America 1.29
2 Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises 5.23
3 Advertising, marketing and brand building 4.95
4 Investment in procuring hardware and software 0.68
5 Funding of working capital requirements 19.75
6 General corporate purposes 1.99

Key Performance Indicator (KPI)

KPIMar 31, 2024
ROE37.86%
ROCE22.95%
Debt/Equity2.16
RoNW31.83%
PAT Margin4.75%
EBITDA Margin14.60%
Price to Book Value8.57
Check IPO Peer Comparison here.
Pre IPOPost IPO
EPS (₹)4.935.20
P/E (x)27.3625.94
Promoter Holding98.42%72.3%
Market Cap₹141.90 Cr.
Ashish Gulati is the promoter of the company.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2024 available in RHP.

IPO Review

[Dilip Davda]
ALL is engaged in contract manufacturing of pharma and cosmetic products for domestic and export markets. While it marked growth in its top lines, its bottom lines boosted fromFY24 onwards and raised eyebrows. Based on its financial data so far, the issue appears fully priced. Well-informed investors may park funds for medium to long term.
Read detail review...

Astonea Labs IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers0100
Members0000

Astonea Labs IPO Subscription Status (Bidding Detail)

The Astonea Labs IPO is subscribed 1.79 times on May 29, 2025 6:19:34 PM (Day 3). The public issue subscribed 1.69 times in the retail category, 0.70 times in the QIB category, and 5.60 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid forTotal Application
QIB0.7013,20,0009,27,0000
NII*5.603,99,00022,33,0000
Retail1.699,27,00015,67,0000
Total1.7926,46,00047,27,0002,190

Total Application : 2,190

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Book Running Lead Manager Fees 0.24
2 Fees Payable to Registrar to the Issue 0.01
3 Fees Payable for Advertising and Publishing Expenses 0.05
4 Fees Payable to Regulators including Stock Exchanges 0.04
5 Payment for Printing & Stationery, Postage, etc 0.02
6 Fees Payable to Legal Advisors and other Professionals 0.04
7 Others (Underwriting fees, Commission/processing fee for SCSBs, Sponsor Bank and Banker(s) to the Issue and brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs, Marketing and Miscellaneous Expenses) 3.38

Listing Day Trading Information

Price DetailsBSE SME
Final Issue Price₹135.00
Open₹137.45
Low₹135.00
High₹140.00
Last Trade₹135.65

Check IPO Performance…

IPO Registrar

Kfin Technologies Ltd.

Contact Details

Astonea Labs Ltd. Address
House No. 1358,
1st Floor,
Sector-22B,
Charkhi Dadri, Chandigarh, 160022
Open an Instant Account with Zerodha

IPO FAQs

Astonea Labs IPO is a SME IPO of 27,90,000 equity shares of the face value of ₹10 aggregating up to ₹38 Crores. The issue is priced at ₹135 per share. The minimum order quantity is 1000.

The IPO opens on Tue, May 27, 2025, and closes on Thu, May 29, 2025.

Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

Zerodha customers can apply online in Astonea Labs IPO using UPI as a payment gateway. Zerodha customers can apply in Astonea Labs IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Astonea Labs IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Astonea Labs IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Astonea Labs IPO opens on Tue, May 27, 2025 and closes on Thu, May 29, 2025.

Astonea Labs IPO lot size is 1000, and the minimum amount required for application is ₹1,35,000.

You can apply in Astonea Labs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Astonea Labs IPO will be done on Friday, May 30, 2025, and the allotted shares will be credited to your demat account by Mon, Jun 2, 2025. Check the Astonea Labs IPO allotment status.

The Astonea Labs IPO listing date is on Tue, Jun 3, 2025.

Quick Links

Compare: